Baricitinib inhibits type Ⅰ IFN-signaling during SARS-CoV-2 infection in vitro

LIANG Wan-xin, ZHANG Su, OU Min, DUAN Lian, ZHANG Guo-liang, LIU Shu-yan

China Tropical Medicine ›› 2022, Vol. 22 ›› Issue (11) : 1056-1061.

PDF(1340 KB)
PDF(1340 KB)
China Tropical Medicine ›› 2022, Vol. 22 ›› Issue (11) : 1056-1061. DOI: 10.13604/j.cnki.46-1064/r.2022.11.11
Articles

Baricitinib inhibits type Ⅰ IFN-signaling during SARS-CoV-2 infection in vitro

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 22(11): 1056-1061 https://doi.org/10.13604/j.cnki.46-1064/r.2022.11.11

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1340 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉